open access

Vol 62, No 4 (2011)
Postgraduate education
Published online: 2011-08-30
Submitted: 2013-02-15
Get Citation

Management of thyroid diseases during pregnancy

A. Hubalewska-Dydejczyk, A. Lewiński, A. Milewicz, S. Radowicki, R. Poręba, M. Karbownik-Lewińska, M. Kostecka-Matyja, M. Trofimiuk-Müldner, D. Pach, A. Zygmunt, E. Bandurska-Stankiewicz, E. Bar-Andziak, T. Bednarczuk, M. Buziak-Bereza, K. Drews, M. Gietka-Czernel, M. Górska, H. Jastrzębska, R. Junik, J. Nauman, M. Niedziela, A. Reroń, J. Sowiński, K. Sworczak, A. Syrenicz, W. Zgliczyński
Endokrynologia Polska 2011;62(4):362-381.

open access

Vol 62, No 4 (2011)
Postgraduate education
Published online: 2011-08-30
Submitted: 2013-02-15

Abstract

The management of thyroid disorders during pregnancy is one of the most frequently disputed problems in modern endocrinology. It is widely known that thyroid dysfunction may result in subfertility, and, if inadequately treated during pregnancy, may cause obstetrical complications and influence fetal development.
The 2007 Endocrine Society Practice Guideline endorsed with the participation of the Latino America Thyroid Association, the American Thyroid Association, the Asia and Oceania Thyroid Association and the European Thyroid Association, greatly contributed towards uniformity of the management of thyroid disorders during pregnancy and postpartum. Despite the tremendous progress in knowledge on the mutual influence of pregnancy and thyroid in health and disease, there are still important areas of uncertainty. There have been at least a few important studies published in the last 3 years, which influenced the thyroidal care of the expecting mother. It should also be remembered that guidelines may not always be universally applied in all populations with different ethnical, socio-economical, nutritional (including iodine intake) background or exposed to different iodine prophylaxis models.
The Task Force for development of guidelines for thyroid dysfunction management in pregnant women was established in 2008. The expert group has recognized the following tasks: development of the coherent model of the management of thyroid dysfunction in pregnant women, identification of the group of women at risk of thyroid dysfunction, who may require endocrine care in the preconception period, during pregnancy and postpartum – that is in other words, the development of Polish recommendations for targeted thyroid disorder case finding during pregnancy, and the development of Polish trimester-specific reference values of thyroid hormones. Comprehensive Polish guidelines developed by the Task Force are to systematize the management of the thyroid disorders in pregnant women in Poland.
(Pol J Endocrinol 2011; 62 (4): 362–381)

Abstract

The management of thyroid disorders during pregnancy is one of the most frequently disputed problems in modern endocrinology. It is widely known that thyroid dysfunction may result in subfertility, and, if inadequately treated during pregnancy, may cause obstetrical complications and influence fetal development.
The 2007 Endocrine Society Practice Guideline endorsed with the participation of the Latino America Thyroid Association, the American Thyroid Association, the Asia and Oceania Thyroid Association and the European Thyroid Association, greatly contributed towards uniformity of the management of thyroid disorders during pregnancy and postpartum. Despite the tremendous progress in knowledge on the mutual influence of pregnancy and thyroid in health and disease, there are still important areas of uncertainty. There have been at least a few important studies published in the last 3 years, which influenced the thyroidal care of the expecting mother. It should also be remembered that guidelines may not always be universally applied in all populations with different ethnical, socio-economical, nutritional (including iodine intake) background or exposed to different iodine prophylaxis models.
The Task Force for development of guidelines for thyroid dysfunction management in pregnant women was established in 2008. The expert group has recognized the following tasks: development of the coherent model of the management of thyroid dysfunction in pregnant women, identification of the group of women at risk of thyroid dysfunction, who may require endocrine care in the preconception period, during pregnancy and postpartum – that is in other words, the development of Polish recommendations for targeted thyroid disorder case finding during pregnancy, and the development of Polish trimester-specific reference values of thyroid hormones. Comprehensive Polish guidelines developed by the Task Force are to systematize the management of the thyroid disorders in pregnant women in Poland.
(Pol J Endocrinol 2011; 62 (4): 362–381)
Get Citation

Keywords

endocrine care; thyroid disorders; obsterical complications; fetal development

About this article
Title

Management of thyroid diseases during pregnancy

Journal

Endokrynologia Polska

Issue

Vol 62, No 4 (2011)

Pages

362-381

Published online

2011-08-30

Bibliographic record

Endokrynologia Polska 2011;62(4):362-381.

Keywords

endocrine care
thyroid disorders
obsterical complications
fetal development

Authors

A. Hubalewska-Dydejczyk
A. Lewiński
A. Milewicz
S. Radowicki
R. Poręba
M. Karbownik-Lewińska
M. Kostecka-Matyja
M. Trofimiuk-Müldner
D. Pach
A. Zygmunt
E. Bandurska-Stankiewicz
E. Bar-Andziak
T. Bednarczuk
M. Buziak-Bereza
K. Drews
M. Gietka-Czernel
M. Górska
H. Jastrzębska
R. Junik
J. Nauman
M. Niedziela
A. Reroń
J. Sowiński
K. Sworczak
A. Syrenicz
W. Zgliczyński

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl